Try our Advanced Search for more refined results

Brief

US Pharma Biz Indivior Cancels London Listing

By Irene Madongo ( July 25, 2025, 10:45 AM BST) -- Pharmaceuticals company Indivior PLC said on Friday that its admission to trading on the London Stock Exchange has been canceled, but that it will retain its U.S. listing, which it believes best reflects the profile of its business....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies